Establishment Labs Holdings Inc. (ESTA) vs Trevi Therapeutics, Inc. (TRVI)

A side-by-side comparison of Establishment Labs Holdings Inc. and Trevi Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ESTA vs TRVI

growth of $100 · dividends reinvested · last 7y
ESTA +155.8% (+14.4%/yr)TRVI +73.9% (+8.2%/yr)ESTA compounded faster over this window
0100200300Start $100202120232025$256$174
ESTA TRVI

ESTA vs TRVI: by the numbers

  • •ESTA is the larger company ($1.92B vs $1.88B market cap).
  • •Both run net losses; TRVI's is the smaller (0.00% vs -15.82% net margin).

Metrics side by side

Valuation

MetricESTATRVI
P/S ratio7.82N/A
P/B ratio88.925.86

Profitability

MetricESTATRVI
Gross margin70.49%0.00%
Operating margin-18.48%0.00%
Net margin-15.82%0.00%
ROE-179.99%-15.90%
ROIC-6.53%-18.51%

Growth (annualized)

MetricESTATRVI
Revenue CAGR (5Y)17.02%N/A
Total return CAGR (5Y)-1.56%61.74%

Frequently asked

How have ESTA and TRVI total returns compared?
Over the past 5 years, ESTA delivered -1.56% and TRVI delivered 61.74% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.